These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7879567)

  • 1. [The characterization of the protective properties of antiplague preparations by using the index of macrophage subpopulation redistribution].
    Vasil'eva GI; Tkachenko LN; Verkina LM; Doroshenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):94-6. PubMed ID: 7879567
    [No Abstract]   [Full Text] [Related]  

  • 2. [The expression of Fc gamma receptors on the surface of macrophages activated by a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Zh (1978); 1990; 52(2):84-8. PubMed ID: 2142978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of a vaccinal strain of Yersinia pestis on lysosome fusion with phagosomes in peritoneal and alveolar macrophages].
    Vasil'eva GI; Kiseleva AK; Doroshenko EP
    Tsitologiia; 1993; 35(6-7):105-8. PubMed ID: 8266559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental protective of fraction I of the plague microbe].
    Pautov VN; Chicherin IuV; Evstigneev VI; Byvalov AA; Kedrov OA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):37-42. PubMed ID: 116458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of different Yersinia pestis antigens on the cellular link in immunity].
    Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals].
    Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of a vaccinal strain of the plague microbe on C3-receptor expression on the surfaces of peritoneal and alveolar macrophages].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Z; 1994; 56(4):25-9. PubMed ID: 9181978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A method of assessing immunogenicity of preparations for plague prevention].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Bespalova IA
    Klin Lab Diagn; 1999 Mar; (3):37-9. PubMed ID: 10234932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent survival of attenuated Yersinia pestis organisms with coexistence of chondroitin sulfate colloidal iron within guinea pig macrophages as an initial step of the induction of potent antiplague immunogenesis.
    Iiponen AL; Wake A; Fukaya F
    Contrib Microbiol Immunol; 1991; 12():230-4. PubMed ID: 1935095
    [No Abstract]   [Full Text] [Related]  

  • 12. Reaction of macrophage disappearance as a method for the evaluation of cellular immunity in experimental plague.
    Vasilieva GI; Kisileva AK; Doroshenko YP; Pustovalov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):123-8. PubMed ID: 1619289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The protective activity of the adhesion pili of Yersinia pestis].
    Vodop'ianov SO; Rybianets AA; Verkina LM; Romanova LV; Sorokina TB; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):26-9. PubMed ID: 8525726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of the macrophage disappearance reaction for detecting delayed hypersensitivity to Yersinia pestis antigens].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Pustovalov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):83-6. PubMed ID: 2099076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The heterogeneity of the alveolar macrophages of guinea pigs immunized subcutaneously with a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Gamleshko KhP; Tkachenko LN; Kiseleva AK; Doroshenko AP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):34-6. PubMed ID: 1801486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
    Elvin SJ; Williamson ED
    Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
    Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early protection of animals, immunized by a recombinant plague vaccine, from experimental plague].
    Gremiakova TA; Amel'chenko VA; Anisimov GA
    Biull Eksp Biol Med; 1995 Jan; 119(1):54-7. PubMed ID: 7718805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development].
    Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI
    Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.